DCOY is trading at $5.92 (-5.90%) in pre-market action on light, catalyst-free trading following a prior session close of $6.30.
- No company-specific catalysts, such as earnings, FDA updates, or regulatory filings, were found to explain the price movement.
- The decline appears linked to broader weakness in U.S. equity indices and futures, which may be weighing on sentiment across the small-cap biotech sector.